Purchase Option

$ 4400
$ 6600
$ 8900

The global Retractable Needle Safety Syringes Market is expected to grow at a CAGR of x% during the forecast period 2022 to 2028. Safety syringes are syringes with inbuilt safety mechanism that prevents reuse of needles. The needle attached to syringes may be removable or permanent. These safety syringes are designed for healthcare workers to avoid needle stick injuries. Retractable needle syringes are a type of safety syringes in which protruding needle is withdrawn into the barrel after the delivery of the dose.  Along with safety, some of syringes offers features such as dose sparing technology which ensures minimal waste of medication and prevents medication errors. Global retractable needle safety syringes market projected to grow at significant rates owing to the increase in awareness related to meddle stick injuries and growing prevalence of the infectious diseases. Many regulatory bodies around the world has taken initiatives to mandate the use of safety syringes in hospitals to prevent the needle stick injuries. For instance in U.S. Needle stick Safety and Prevention Act was enforced in 2001 to prevent the needle stick injuries and promoting the safety injectors. Similarly, The Nigerian government issued a deadline on October 1, 2012 for phasing out of conventional syringes and usage of auto-disable syringes in its health institutions. Market players are adopting various strategies such as mergers and acquisitions to improve their market share. Many market players are advancing the safety syringe technologies by incorporating new features such as dose sparing technology to ensure minimal waste of medication.

Global Retractable Needle Safety Syringes Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

North America

Fastest Growing Market

MEA
Retractable Needle Safety Syringes Market Dynamics

Primary driving factors for retractable needle safety syringes are escalating number of needle stick injuries, rising awareness and growing number of geriatric population who are more prone to diseases such as diabetes and other chronic diseases. Furthermore, increase in prevalence of the infectious diseases around the world such as AIDS, Ebola and Malaria projected to boost market share over the forecast period. According to U.S. Occupational Safety and Health Administration (OSHA), about 5.6 Mn healthcare workers across the U.S. are under the high risk of blood borne diseases via needle stick and sharp related injuries. However, the presence of alternative drug delivery procedures and adoptability of retractable needle safety syringes in emerging countries expected to hamper the market share over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Retractable Needle Safety Syringes Market Segmentation

Type
  • Manual
  • Automatic
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others
Geography
  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Becton, Dickinson & Company (U.S.)
  • Medtronic (U.S.)
  • Revolutions Medical Corporation (U.S.)
  • Retractable Technologies, Inc. (U.S.)
  • Royal Imtech N.V. (Smiths Medical) (Netherlands
  • Terumo Corporation (Japan)
  • Unilife Corporation (U.S.)
  • Sol-Millennium Medical Group (China)
  • Ultimed, Inc. (U.S.)
  • Axel Bio Corporation (U.S.)

Adjacent Markets